GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of T-helper 1 cell cytokine production | ||
immune response | ||
positive regulation of type II interferon production | ||
positive regulation of neutrophil extravasation | ||
inflammatory response |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular region | ||
external side of plasma membrane | ||
plasma membrane | ||
membrane |
GO Term | Evidence Code | PMID |
---|---|---|
protein binding | ||
protease binding | ||
interleukin-1, type I, activating receptor activity | ||
interleukin-1 receptor activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110048 | Alzheimer's disease 15 | |
DOID:0110115 | autoimmune lymphoproliferative syndrome type 2A | |
DOID:0110116 | autoimmune lymphoproliferative syndrome type 2B | |
DOID:0110119 | autoimmune lymphoproliferative syndrome type 3 | |
DOID:0110741 | type 1 diabetes mellitus 2 | |
DOID:0110742 | type 1 diabetes mellitus 3 | |
DOID:0110743 | type 1 diabetes mellitus 4 | |
DOID:0110744 | type 1 diabetes mellitus 5 | |
DOID:0110745 | type 1 diabetes mellitus 6 | |
DOID:0110746 | type 1 diabetes mellitus 7 |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0001945 | Fever |
HP:0002653 | Bone pain |
HP:0002754 | Osteomyelitis |
HP:0003565 | Elevated erythrocyte sedimentation rate |
HP:0100847 | Palmoplantar pustulosis |
Disease ID | Disease Name |
---|---|
OMIM:259680 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
711726 | MACMU08638 | ||
105490126 | MACNE13391 | ||
101003909 | PAPAN09600 | ||
105531618 | MANLE02031 | ||
101133600 | GORGO25467 | ||
100972617 | PANPA25413 | ||
459460 | PANTR28348 | ||
481328 | CANLF01744 | ||
112915144 | VULVU06625 | ||
123775960 | URSAM11340 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024